International Stem Cell (ISCO) Capital Expenditures (2010 - 2025)
International Stem Cell's (ISCO) quarterly Capital Expenditures came in at $3000.0 in Q4 2025, up 200.0% year-over-year from $1000.0 in Q4 2024, and little changed quarter-over-quarter from $3000.0 in Q3 2025.
Powered by 
Analysis
International Stem Cell (ISCO) Capital Expenditures (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Capital Expenditures for 15 consecutive years, with $3000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Capital Expenditures rose 200.0% year-over-year to $3000.0 in Q4 2025; TTM through Dec 2025 was $43000.0, a 74.1% decrease from a year earlier, with the FY2025 full-year figure at $43000.0, down 74.1% from the prior year.
- Capital Expenditures was $3000.0 for Q4 2025 at International Stem Cell, roughly flat from $3000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $120000.0 in Q2 2024 and troughed at $1000.0 in Q4 2024.
- A 4-year average of $24916.7 and a median of $12000.0 in 2021 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 200.0% in 2025, down 91.89% in 2025.
- Over 4 years, Capital Expenditures stood at $10000.0 in 2021, then surged by 40.0% to $14000.0 in 2023, then sank by 92.86% to $1000.0 in 2024, then soared by 200.0% to $3000.0 in 2025.
- The last three Capital Expenditures figures came in at $3000.0 (Q4 2025), $3000.0 (Q3 2025), and $32000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 3.57 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | 648,000.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | 5.44 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | -7.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | 472,000.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 2.41 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 392,000.00 |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.39 Bn | 251.87 Mn | 555,000.00 |
| 9 | Vericel | 1.96 Bn | 1.79 Bn | 56.40 Mn | 1.73 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 55,000.00 |
| Mar 31, 2019 | 58,000.00 |